Behboudi et al., 2019 - Google Patents
Carbon quantum dots in nanobiotechnologyBehboudi et al., 2019
View PDF- Document ID
- 1601915522040957947
- Author
- Behboudi H
- Mehdipour G
- Safari N
- Pourmadadi M
- Saei A
- Omidi M
- Tayebi L
- Rahmandoust M
- Publication year
- Publication venue
- Nanomaterials for advanced biological applications
External Links
Snippet
There has been an outburst of attraction in the use of nanoparticles and nanomaterials for bioimaging, biosensing and other chemical and biological applications. At the leading edge of the new trend of the emerging nanoparticles in the carbonic nanomaterials family …
- 150000001721 carbon 0 title abstract description 32
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
- A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
- A61K47/48769—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form
- A61K47/48853—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere
- A61K47/48861—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the conjugate being characterized by a special physical or galenical form the form being a particulate, powder, adsorbate, bead, sphere the form being an inorganic particle, e.g. a ceramic particle, silica particle, ferrite, synsorb
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
- A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
- A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
- A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
- A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Behboudi et al. | Carbon quantum dots in nanobiotechnology | |
| Azam et al. | Carbon quantum dots for biomedical applications: review and analysis | |
| Das et al. | Carbon quantum dots in bioimaging and biomedicines | |
| Molaei | Carbon quantum dots and their biomedical and therapeutic applications: a review | |
| Zhao et al. | Near-infrared light-triggered lysosome-targetable carbon dots for photothermal therapy of cancer | |
| Su et al. | Carbon dots: a booming material for biomedical applications | |
| Tong et al. | One-step fabrication of functional carbon dots with 90% fluorescence quantum yield for long-term lysosome imaging | |
| Guo et al. | Boron quantum dots for photoacoustic imaging-guided photothermal therapy | |
| Ali et al. | Fluorescent carbon dots as intracellular imaging probes | |
| Zhang et al. | Exploring heterostructured upconversion nanoparticles: from rational engineering to diverse applications | |
| Bao et al. | Hyperthemia-promoted cytosolic and nuclear delivery of copper/carbon quantum dot-crosslinked nanosheets: multimodal imaging-guided photothermal cancer therapy | |
| Xu et al. | Carbon quantum dot stabilized gadolinium nanoprobe prepared via a one-pot hydrothermal approach for magnetic resonance and fluorescence dual-modality bioimaging | |
| Li et al. | Technical synthesis and biomedical applications of graphene quantum dots | |
| Bao et al. | Luminescence of carbon quantum dots and their application in biochemistry | |
| Singh et al. | Carbon quantum dots: Synthesis, characterization and biomedical applications | |
| Dong et al. | Multimode imaging-guided photothermal/chemodynamic synergistic therapy nanoagent with a tumor microenvironment responded effect | |
| Qu et al. | Recent advance of carbon dots in bio-related applications | |
| Ali et al. | Red fluorescent carbon nanoparticle-based cell imaging probe | |
| Dai et al. | Mussel-inspired polydopamine-coated lanthanide nanoparticles for NIR-II/CT dual imaging and photothermal therapy | |
| Cui et al. | Gold nanoclusters–indocyanine green nanoprobes for synchronous cancer imaging, treatment, and real-time monitoring based on fluorescence resonance energy transfer | |
| Yang et al. | A single 808 nm near-infrared light-mediated multiple imaging and photodynamic therapy based on titania coupled upconversion nanoparticles | |
| Ostadhossein et al. | Functional carbon nanodots for multiscale imaging and therapy | |
| Mohapatra et al. | Highly hydrophilic luminescent magnetic mesoporous carbon nanospheres for controlled release of anticancer drug and multimodal imaging | |
| Lei et al. | Optimization of Bi3+ in upconversion nanoparticles induced simultaneous enhancement of near-infrared optical and X-ray computed tomography imaging capability | |
| Wang et al. | Spectral engineering of lanthanide-doped upconversion nanoparticles and their biosensing applications |